LD-2 disclosure · 1st Quarter - Report
PHARMATHENE
via HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)
Coverage · No income or expenses were reported on this filing.
Client
- Name
- PHARMATHENE
- Description
- Medical/Disease research and work with clinical labs
- Location
- * Undetermined
Registrant
- Firm
- HOGAN LOVELLS CADWALADER US LLP (FKA HOGAN LOVELLS US LLP)
- Description
- Law Firm
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
2 issuesBudget/Appropriations
FY 2013 Labor, Health & Human Services, Education and Related Agencies
LobbyistsCHRISTINE M WARNKE
TargetedSENATE · HOUSE OF REPRESENTATIVES
Medical/Disease Research/Clinical Labs
HR 2405, Pandemic All-Hazard Preparedness Reauthorization Act.S 1855.
LobbyistsCHRISTINE M WARNKE
TargetedSENATE · HOUSE OF REPRESENTATIVES